Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...
Forbes8mon
Why Bristol Myers Squibb Is A Top Socially Responsible Dividend Stock
We provide aggregated data on dividend stocks. Bristol Myers Squibb has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ...